1. Home
  2. SFBS vs CRNX Comparison

SFBS vs CRNX Comparison

Compare SFBS & CRNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SFBS
  • CRNX
  • Stock Information
  • Founded
  • SFBS 2005
  • CRNX 2008
  • Country
  • SFBS United States
  • CRNX United States
  • Employees
  • SFBS N/A
  • CRNX N/A
  • Industry
  • SFBS Major Banks
  • CRNX Biotechnology: Pharmaceutical Preparations
  • Sector
  • SFBS Finance
  • CRNX Health Care
  • Exchange
  • SFBS Nasdaq
  • CRNX Nasdaq
  • Market Cap
  • SFBS 4.5B
  • CRNX 5.2B
  • IPO Year
  • SFBS 2014
  • CRNX 2018
  • Fundamental
  • Price
  • SFBS $81.93
  • CRNX $32.33
  • Analyst Decision
  • SFBS Hold
  • CRNX Strong Buy
  • Analyst Count
  • SFBS 1
  • CRNX 12
  • Target Price
  • SFBS $96.00
  • CRNX $73.36
  • AVG Volume (30 Days)
  • SFBS 245.5K
  • CRNX 956.8K
  • Earning Date
  • SFBS 04-21-2025
  • CRNX 05-08-2025
  • Dividend Yield
  • SFBS 1.64%
  • CRNX N/A
  • EPS Growth
  • SFBS 9.76
  • CRNX N/A
  • EPS
  • SFBS 4.16
  • CRNX N/A
  • Revenue
  • SFBS $458,732,000.00
  • CRNX $1,039,000.00
  • Revenue This Year
  • SFBS $27.73
  • CRNX $394.51
  • Revenue Next Year
  • SFBS $10.90
  • CRNX $699.82
  • P/E Ratio
  • SFBS $19.70
  • CRNX N/A
  • Revenue Growth
  • SFBS 11.73
  • CRNX N/A
  • 52 Week Low
  • SFBS $58.11
  • CRNX $31.84
  • 52 Week High
  • SFBS $101.37
  • CRNX $62.53
  • Technical
  • Relative Strength Index (RSI)
  • SFBS 37.34
  • CRNX 46.96
  • Support Level
  • SFBS $80.63
  • CRNX $32.90
  • Resistance Level
  • SFBS $85.33
  • CRNX $36.45
  • Average True Range (ATR)
  • SFBS 1.78
  • CRNX 1.42
  • MACD
  • SFBS 0.04
  • CRNX 0.26
  • Stochastic Oscillator
  • SFBS 11.37
  • CRNX 51.49

About SFBS ServisFirst Bancshares Inc.

Servisfirst Bancshares Inc is a bank holding company whose business is conducted by its wholly owned subsidiary, ServisFirst Bank. Through the bank, it offers various banking services to individual and corporate customers in Birmingham, Florida, Georgia, North Carolina, South Carolina, Tennessee, and Virginia. Its various products and service offerings include commercial, consumer, and other loans; accepting deposits; providing electronic banking services, such as online and mobile banking, including remote deposit capture; delivering treasury and cash management services; and providing banking services to other financial institutions. The company operates as a single reportable segment, with a majority of its revenue being derived from the business of banking.

About CRNX Crinetics Pharmaceuticals Inc.

Crinetics Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors.

Share on Social Networks: